rs146696590

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 1P and 7B. PP3BP4_ModerateBP6BS1

The NM_001080476.3(GRXCR1):​c.785G>A​(p.Arg262Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000679 in 1,613,960 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R262L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00061 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 0 hom. )

Consequence

GRXCR1
NM_001080476.3 missense

Scores

6
6
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 9.51

Publications

18 publications found
Variant links:
Genes affected
GRXCR1 (HGNC:31673): (glutaredoxin and cysteine rich domain containing 1) This gene is one of 60 loci associated with autosomal-recessive nonsyndromic hearing impairment. This gene encodes a protein which contains GRX-like domains; these domains play a role in the S-glutathionylation of proteins and may be involved in actin organization in hair cells. [provided by RefSeq, Sep 2010]
GRXCR1 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 25
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, Cadd, Dann, Eigen, FATHMM_MKL, phyloP100way_vertebrate, PrimateAI [when BayesDel_addAF, max_spliceai, M_CAP, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.082303464).
BP6
Variant 4-43030452-G-A is Benign according to our data. Variant chr4-43030452-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 228734.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000611 (93/152110) while in subpopulation NFE AF = 0.000971 (66/67996). AF 95% confidence interval is 0.000782. There are 1 homozygotes in GnomAd4. There are 40 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRXCR1NM_001080476.3 linkc.785G>A p.Arg262Gln missense_variant Exon 4 of 4 ENST00000399770.3 NP_001073945.1 A8MXD5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRXCR1ENST00000399770.3 linkc.785G>A p.Arg262Gln missense_variant Exon 4 of 4 1 NM_001080476.3 ENSP00000382670.2 A8MXD5

Frequencies

GnomAD3 genomes
AF:
0.000612
AC:
93
AN:
151992
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000967
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000971
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000713
AC:
178
AN:
249478
AF XY:
0.000650
show subpopulations
Gnomad AFR exome
AF:
0.000129
Gnomad AMR exome
AF:
0.00125
Gnomad ASJ exome
AF:
0.00347
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000928
Gnomad NFE exome
AF:
0.000786
Gnomad OTH exome
AF:
0.000826
GnomAD4 exome
AF:
0.000686
AC:
1003
AN:
1461850
Hom.:
0
Cov.:
31
AF XY:
0.000638
AC XY:
464
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33478
American (AMR)
AF:
0.00116
AC:
52
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00333
AC:
87
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86256
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53420
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.000731
AC:
813
AN:
1111978
Other (OTH)
AF:
0.000530
AC:
32
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
65
130
196
261
326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000611
AC:
93
AN:
152110
Hom.:
1
Cov.:
32
AF XY:
0.000538
AC XY:
40
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.0000964
AC:
4
AN:
41496
American (AMR)
AF:
0.000197
AC:
3
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000971
AC:
66
AN:
67996
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000810
Hom.:
2
Bravo
AF:
0.000597
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000963
AC:
8
ExAC
AF:
0.000579
AC:
70
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00120
EpiControl
AF:
0.00107

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 01, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Aug 24, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Arg262Gln variant in GRXCR1 has been identified by our laboratory in 2 ind ividuals with hearing loss; however a second variant was not identified in eithe r individual. The variant has also been identified in 0.4% (36/10150) of Ashkena zi Jewish and 0.1% (102/126588) of European chromosomes by the Genome Aggregatio n Database (gnomAD, http://gnomad.broadinstitute.org/; rs146696590) and has been reported in ClinVar (Variation ID: 228734); however its frequency is not high e nough to rule out a pathogenic role. Computational prediction tools and conserva tion analysis suggest the variant may impact the protein; however this data is i nsufficient to assume pathogenicity. In summary, the clinical significance of th e p.Arg262Gln variant is uncertain. -

Autosomal recessive nonsyndromic hearing loss 25 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

GRXCR1-related disorder Benign:1
Jul 19, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.71
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.41
T
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.045
D
MetaRNN
Benign
0.082
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
9.5
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-3.4
D
REVEL
Uncertain
0.35
Sift
Uncertain
0.023
D
Sift4G
Benign
0.44
T
Polyphen
1.0
D
Vest4
0.87
MVP
0.47
MPC
0.28
ClinPred
0.092
T
GERP RS
5.6
Varity_R
0.25
gMVP
0.60
Mutation Taster
=41/59
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146696590; hg19: chr4-43032469; COSMIC: COSV67669808; API